Sai Santosh Kumar Bhuvanagiri, MD
Endocrinology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Doctors Medical Center · Emanuel Medical Center · Memorial Medical Center · Mercy Medical Center · Oak Valley Hospital District. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhuvanagiri’s office at (510) 490-1222 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Doctors Medical CenterModesto, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 59% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.02 to 1.71), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.35 (0.81 to 1.9) · 6,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.281, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.326, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.183, Oct 2024 – Sep 2025
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
- Oak Valley Hospital DistrictOakdale, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentOverall rating: 1 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Doctors Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 3 the same, 1 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.02 to 1.71) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.35 (0.81 to 1.9) · 6,296 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.281 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.326 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.27 (0.31 to 2.23) · 1,396 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.31 (147.26 to 219.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.1 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.2 · 276 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.8 · 321 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 3,719 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,169 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.12 (2.19 to 6.06) · 1,622 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.23 to 4.04) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.79 (5.73 to 23.85) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (0.75 to 9.23) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.9 · 67 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.484 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.582 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 424 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24 · 682 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 36.6 · 326 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 70.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 366 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 564 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.7 · 120 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.4) · 573 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 303 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,045 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 57% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Oak Valley Hospital District
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.47 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 19.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 122 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 391 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.88) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Hospital return days for heart failure patientsUnplanned return visits | 113.4 · 27 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 48.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.7) · 186 cases | No different | Jan 2022 – Dec 2024 |
Original Medicare doctor bills
$95,098
Medicare paid this office $95,098 for 303 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 271 | $44,767 | $92 |
| Injection, denosumab, 1 mg | 21 | $33,944 | None |
| New patient visit (45+ min) | 83 | $8,437 | $102 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 183 | $3,396 | $13 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 64 | $2,663 | $27 |
See all 8 services
| Return visit (30+ min) | 271 | $44,767 | $92 |
| Injection, denosumab, 1 mg | 21 | $33,944 | None |
| New patient visit (45+ min) | 83 | $8,437 | $102 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 183 | $3,396 | $13 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 64 | $2,663 | $27 |
| Short return visit (20+ min) | 14 | $930 | $66 |
| Injection of drug or substance under skin or into muscle | 22 | $367 | $12 |
| Hemoglobin a1c level | 15 | $143 | $10 |
Who their Medicare patients are
303 Original Medicare patients in 2024. Average age 68 · Women 70% · Also on Medicaid 54% · Health risk score 1.44. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 65% · Chronic kidney disease 28% · Coronary heart disease 22% · Depression 22% · Atrial fibrillation 16% · Heart failure 14% · COPD 14% · Cancer 11% · Stroke 7% · Dementia 5%.
The office billed $295,868, Medicare allowed $129,078 and paid $95,098; for 2,636 services of 13 kinds; $33,964 of it was for drugs given in the office and $61,134 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 303 | 2,636 | 68 | 1.44 | $295,868 | $95,098 |
| 2023 | 205 | 1,144 | 68 | 1.69 | $211,642 | $60,348 |
| 2022 | 71 | 108 | 68 | 1.40 | $40,997 | $11,944 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 159 | $30,893 | $90 |
| New patient visit (45+ min) | 145 | $15,782 | $109 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 31 | $1,443 | $26 |
| Ultrasound scan of head and neck soft tissue | 12 | $1,027 | $79 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 11 | $517 | $47 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 15 | $218 | $15 |
2022: 2 services
| New patient visit (45+ min) | 71 | $9,080 | $128 |
| Return visit (30+ min) | 19 | $2,097 | $105 |
Medicaid work
$70,113 in 2024
Medicaid paid $70,113 for 2,178 billed services this clinician did in 2024, up to 122 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,038 | $44,994 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 157 | $17,253 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 136 | $4,027 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 16 | $2,663 |
| New patient visit (45+ min) | 19 | $1,176 |
| TOBACCO NON-USER | 285 | $0 |
| Medication list documented in medical record (COA) | 30 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 30 | $0 |
| BODY MASS INDEX DOCD | 179 | $0 |
| HEMOGLOBIN A1C LEVEL >9.0% | 27 | $0 |
| Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7.0% and less than 8.0% (DM) | 28 | $0 |
| Most recent hemoglobin A1c (HbA1c) level greater than or equal to 8.0% and less than or equal to 9.0% (DM) | 17 | $0 |
| 2024 | 2,178 | 14 | 122 | $70,113 |
| 2023 | 1,624 | 8 | 89 | $59,362 |
| 2022 | 124 | 5 | 28 | $839 |
| 2021 | 116 | 3 | 17 | $726 |
See the largest Medicaid services in earlier years
2023
| OFF/OP CNSLTJ NEW/EST MOD 40 | 270 | $29,634 |
| Return visit (30+ min) | 635 | $24,602 |
| New patient visit (45+ min) | 100 | $5,127 |
| TOBACCO NON-USER | 201 | $0 |
| Medication list documented in medical record (COA) | 115 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 115 | $0 |
| BODY MASS INDEX DOCD | 115 | $0 |
| Screening for depression performed (DEM) | 73 | $0 |
2022
| New patient visit (45+ min) | 28 | $400 |
| Thyroid stimulating hormone (TSH) | 12 | $202 |
| Measurement of free thyroxine | 23 | $135 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 49 | $102 |
| TOBACCO NON-USER | 12 | $0 |
2021
| Thyroid stimulating hormone (TSH) | 26 | $336 |
| Measurement of free thyroxine | 43 | $298 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 47 | $93 |
Drugs they prescribed that Part D paid
$2,215,763
Pharmacies billed $2,215,763 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,346) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,566 generic and 2,417 brand-name prescriptions · $2,215,763 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 508 | $725,364 | $1,428 |
| Mounjaro | 228 | $263,699 | $1,157 |
| Jardiance | 255 | $247,112 | $969 |
| Trulicity | 183 | $182,593 | $998 |
| Rybelsus | 119 | $140,322 | $1,179 |
See all 53 drugs
| Ozempic | 508 | $725,364 | $1,428 |
| Mounjaro | 228 | $263,699 | $1,157 |
| Jardiance | 255 | $247,112 | $969 |
| Trulicity | 183 | $182,593 | $998 |
| Rybelsus | 119 | $140,322 | $1,179 |
| Forteo | 21 | $93,957 | $4,474 |
| Teriparatide | 35 | $84,324 | $2,409 |
| Evenity (2 Syringes) | 35 | $79,911 | $2,283 |
| Basaglar Kwikpen U-100 | 109 | $50,439 | $463 |
| Lantus Solostar | 279 | $36,401 | $130 |
| Humalog Kwikpen U-100 | 127 | $35,194 | $277 |
| Prolia | 17 | $28,636 | $1,684 |
| Tresiba Flextouch U-100 | 34 | $26,030 | $766 |
| Nano 2nd Gen Pen Needle | 207 | $17,677 | $85 |
| Farxiga | 11 | $16,495 | $1,500 |
| Synjardy | 16 | $14,676 | $917 |
| Novolog Flexpen | 56 | $14,646 | $262 |
| Insulin Lispro Kwikpen U-100 | 55 | $9,654 | $176 |
| Fiasp Flextouch | 16 | $8,449 | $528 |
| Humalog | 19 | $5,802 | $305 |
| Levothyroxine | 365 | $5,094 | $14 |
| Baqsimi | 12 | $4,920 | $410 |
| Liothyronine | 94 | $4,039 | $43 |
| Humulin N Kwikpen | 20 | $3,501 | $175 |
| Pregabalin | 50 | $3,201 | $64 |
| Ultra-Fine Micro Pen Needle | 19 | $2,961 | $156 |
| Metformin | 281 | $2,597 | $9 |
| Droplet Pen Needle | 21 | $1,609 | $77 |
| Atorvastatin | 137 | $1,543 | $11 |
| Humulin N | 12 | $1,445 | $120 |
| Ultra-Fine Short Pen Needle | 11 | $1,316 | $120 |
| Synthroid | 23 | $1,300 | $57 |
| Insulin Lispro | 11 | $1,283 | $117 |
| Glipizide | 142 | $1,238 | $9 |
| Acarbose | 20 | $1,055 | $53 |
| Methimazole | 52 | $1,015 | $20 |
| Glipizide Er | 52 | $908 | $17 |
| Ultra-Fine Nano Pen Needle | 12 | $881 | $73 |
| Metformin Hcl Er | 97 | $863 | $9 |
| Lantus | 12 | $808 | $67 |
| Veo Insulin | 12 | $787 | $66 |
| Ondansetron | 21 | $753 | $36 |
| Calcitriol | 15 | $598 | $40 |
| Gabapentin | 40 | $591 | $15 |
| Rosuvastatin | 15 | $590 | $39 |
| Armour Thyroid | 12 | $480 | $40 |
| Alendronate | 35 | $440 | $13 |
| Fenofibrate | 12 | $407 | $34 |
| Glimepiride | 41 | $336 | $8 |
| Vitamin D2 | 31 | $264 | $9 |
| Pantoprazole | 13 | $174 | $13 |
| Simvastatin | 13 | $160 | $12 |
| Dexamethasone | 20 | $14 | $1 |
Year by year
| 2024 | 4,346 | 557 | 0% (0) | 56% | $2,215,763 |
| 2023 | 1,732 | 279 | 0% (0) | 55% | $1,047,346 |
| 2022 | 254 | 73 | None | 52% | $94,024 |
| 2021 | 175 | 39 | 0% (0) | 38% | $41,057 |
| 2020 | 124 | 37 | 0% (0) | None | $16,547 |
| 2019 | 263 | 38 | 0% (0) | 20% | $58,336 |
| 2018 | 619 | 86 | 0% (0) | 22% | $47,387 |
| 2017 | 247 | 41 | 0% (0) | None | $22,360 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Jardiance | 145 | $201,980 | $1,393 |
| Ozempic | 144 | $193,650 | $1,345 |
| Rybelsus | 102 | $146,919 | $1,440 |
| Novolog Flexpen | 93 | $63,053 | $678 |
| Forteo | 12 | $57,979 | $4,832 |
| Mounjaro | 42 | $56,046 | $1,334 |
| Cinacalcet | 21 | $54,773 | $2,608 |
| Lantus Solostar | 95 | $48,988 | $516 |
| Trulicity | 33 | $39,458 | $1,196 |
| Humalog Kwikpen U-100 | 42 | $31,621 | $753 |
| Basaglar Kwikpen U-100 | 54 | $26,716 | $495 |
| Nano 2nd Gen Pen Needle | 77 | $6,959 | $90 |
| Gvoke Hypopen 2-Pack | 11 | $6,894 | $627 |
| Pregabalin | 83 | $4,744 | $57 |
| Levothyroxine | 156 | $3,917 | $25 |
| Insulin Lispro Kwikpen U-100 | 21 | $3,465 | $165 |
| Metformin | 128 | $2,588 | $20 |
| Liothyronine | 27 | $1,919 | $71 |
| Methimazole | 29 | $913 | $31 |
| Droplet Pen Needle | 11 | $887 | $81 |
| Glipizide | 48 | $782 | $16 |
| Ultra-Fine Mini Pen Needle | 12 | $719 | $60 |
| Atorvastatin | 28 | $515 | $18 |
| Metformin Hcl Er | 29 | $492 | $17 |
| Gabapentin | 17 | $453 | $27 |
| Glimepiride | 19 | $350 | $18 |
| Pantoprazole | 16 | $227 | $14 |
2022: 7 drugs
| Cinacalcet | 14 | $24,773 | $1,770 |
| Jardiance | 16 | $15,710 | $982 |
| Lantus Solostar | 11 | $7,297 | $663 |
| Levothyroxine | 50 | $643 | $13 |
| Hydrocortisone | 21 | $477 | $23 |
| Methimazole | 27 | $110 | $4 |
| Euthyrox | 15 | $82 | $5 |
2021: 4 drugs
| Levothyroxine | 45 | $696 | $15 |
| Hydrocortisone | 16 | $355 | $22 |
| Ulticare Pen Needle | 11 | $220 | $20 |
| Methimazole | 11 | $167 | $15 |
2020: 1 drug
| Levothyroxine | 11 | $257 | $23 |
2019: 6 drugs
| Symbicort | 13 | $4,561 | $351 |
| Atorvastatin | 13 | $155 | $12 |
| Simvastatin | 14 | $77 | $5 |
| Losartan | 15 | $73 | $5 |
| Metformin | 24 | $63 | $3 |
| Lisinopril | 11 | $47 | $4 |
2018: 18 drugs
| Symbicort | 27 | $9,112 | $337 |
| Proair Hfa | 15 | $890 | $59 |
| Rosuvastatin | 15 | $860 | $57 |
| Ventolin Hfa | 11 | $587 | $53 |
| Fluticasone Propionate | 35 | $335 | $10 |
| Atorvastatin | 29 | $233 | $8 |
| Simvastatin | 21 | $183 | $9 |
| Isosorbide Mononitrate Er | 11 | $141 | $13 |
| Metformin | 23 | $120 | $5 |
| Levothyroxine | 12 | $114 | $10 |
| Gabapentin | 19 | $103 | $5 |
| Amlodipine Besylate | 23 | $102 | $4 |
| Pantoprazole | 13 | $102 | $8 |
| Losartan | 15 | $71 | $5 |
| Lisinopril | 15 | $67 | $4 |
| Clopidogrel | 11 | $63 | $6 |
| Metoprolol | 13 | $49 | $4 |
| Hydrochlorothiazide | 14 | $27 | $2 |
2017: 4 drugs
| Metoprolol | 11 | $181 | $16 |
| Losartan | 12 | $98 | $8 |
| Amlodipine Besylate | 18 | $41 | $2 |
| Furosemide | 13 | $30 | $2 |
Money from drug and device companies
$46 in 2023
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $46 | 2 payments
|
See all 2 published payments
| Novo Nordisk | Meals · 2023-03-23 | Wegovy | $21 |
| Novo Nordisk | Meals · 2023-01-31 | Ozempic | $24 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134652266
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2017-04-05
- NPI last updated
- 2026-03-19
- NPI record certified
- 2026-03-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 497 E Calaveras Blvd, Milpitas, CA, 95035 · 1541 Florida Ave Ste 200, Modesto, CA, 95350